| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080182237 MiRNAs; diagnosis, prognosis, and treatments; drug screening; linear amplification and labeling for hybridization techniques like Luminex and Microarray analysis; gene expression inhibition |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181938 containing lipids and an alcohol; gene therapy; further includes a biocide, benzethonium chloride; permeation enhancer |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181898 Wise/sost nucleic acid sequences and amino acid sequences |
| 07/31/2008 | US20080181881 drug screening a polypeptide antagonist or antibody that binds to the acid-sensing ion channel 3; antisense nucleic acid that inhibit or decreases the expression level of the acid-sensing ion channel 3; treating glucose intolerance of metabolic disorders |
| 07/31/2008 | US20080181875 being overexpressed in transplanted cells, the cyclophilin protein, as antioxydant and peptidyl prolyl cis trans isomerase ligand, remarkably reduces cytotoxicity induced by immunosuppressant cyclosporin A, so that it can greatly improve the success rate in transplantation; myoblast cell line |
| 07/31/2008 | US20080181874 from tumor cell line AKCV-1; transfected with interferon alpha and GMCS; with failing to overexpress estrogen receptors, overexpressing her2/neu, sensitivity in vitro to cyclophosphamide, etoposide, taxol, resistance to carboplatin, karyotypic abnormalities, and aneuploidy; whole cell tumor vaccine |
| 07/31/2008 | US20080181872 adeno-associated virus vector biodrug for Parkinson's disease, Huntington's disease, Alzheimer's disease, Down syndrome, rheumatoid arthritis, Crohn's disease; gene therapy of amyotrophic lateral sclerosis; drug creening; sustained release for prevent oxidative damage from superoxide buildup |
| 07/31/2008 | US20080181871 Focal calcium channel modulation |
| 07/31/2008 | US20080181867 preparing a pre-concentrate by emulsifying an oil phase castor oil with water and a water soluble pharmaceutically active substance cyclosporine A, then dilute to desired concentration; eye drops for eye disorders; less time and low energy consuming, no negative impact on the chemical stability |
| 07/31/2008 | US20080181865 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/31/2008 | DE102006051623A1 Gene transfer into target cells in vivo comprises applying a gene transfer vector and a transduction enhancer at the same time and place |
| 07/30/2008 | EP1950307A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 07/30/2008 | EP1950297A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 07/30/2008 | EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis |
| 07/30/2008 | EP1949916A1 Chromatin remodeling agents for increasing expression of PDX-1 and promoting cell differentiation |
| 07/30/2008 | EP1949907A1 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 07/30/2008 | EP1948810A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 07/30/2008 | EP1948792A1 Conditionally replicating viruses and methods for cancer virotherapy |
| 07/30/2008 | EP1948247A2 Compositions for coordinated vegf and pdgf expression, and methods of use |
| 07/30/2008 | EP1948245A2 Compositions and their uses for gene therapy of bone conditions |
| 07/30/2008 | EP1494752B1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 07/30/2008 | EP1465995B1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 07/30/2008 | EP1289567B1 Lyophilizable and enhanced compacted nucleic acids |
| 07/30/2008 | EP1226170B1 Human chordin and polynucleotides encoding the same |
| 07/30/2008 | EP1159438B1 Use of adenoviral vector for synovial cell transduction |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP0994728B1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 07/30/2008 | EP0912738B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 07/30/2008 | EP0862616B1 Reconstituted mineralized cartilage tissue |
| 07/30/2008 | CN101233231A Anti-obesity agent and anti-obesity food |
| 07/30/2008 | CN101232904A Neuroprotective effective compound |
| 07/30/2008 | CN101232897A Angiogenetic agent containing adrenomedulin as the active ingredient |
| 07/30/2008 | CN101232894A Anticancer agent to be combined with telomelysin |
| 07/30/2008 | CN101230336A Gm-negative ehv-mutants |
| 07/30/2008 | CN101230100A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/30/2008 | CN101229381A Acute promyelocytic leukemia DNA vaccine, preparing method thereof and applications |
| 07/30/2008 | CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets |
| 07/30/2008 | CN100406466C Nucleic acid hydrolysis cutting agent based on cucurbituril |
| 07/30/2008 | CN100406057C Amelioration of effects of cigarette smoke |
| 07/29/2008 | US7405292 Small, interfering RNA (siRNA) molecules which inhibit expression of HALP (HIV-Associated Life Preserver) protein cloned into a plasmid or retroviral vector for introduction into host cells; screening HIV-modulating componds which prevent apoptosis resistance of infected cell; gene therapy |
| 07/29/2008 | US7405278 Chimeric human-type vascular endothelial cell growth factor |
| 07/29/2008 | US7405193 Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 07/29/2008 | US7405080 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/29/2008 | US7405075 Detecting binding between serum and peptide; immunogenic; vaccines |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | US7404950 Induced activation in dendritic cell |
| 07/29/2008 | CA2413670C Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis |
| 07/29/2008 | CA2375383C Modulators of methylation for control of bacterial virulence |
| 07/29/2008 | CA2332623C Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 07/24/2008 | WO2008089448A2 Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis |
| 07/24/2008 | WO2008089329A2 Novel activation and transfer cascade for ubiquitin |
| 07/24/2008 | WO2008089281A2 Methods of treating diabetes |
| 07/24/2008 | WO2008089267A1 Non-human animals with human-glial chimeric brains |
| 07/24/2008 | WO2008089265A2 Anti-viral methods and compositions |
| 07/24/2008 | WO2008089003A2 System for optical stimulation of target cells |
| 07/24/2008 | WO2008088895A2 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma |
| 07/24/2008 | WO2008088882A2 Methods of generating cardiomyocytes |
| 07/24/2008 | WO2008088858A2 Compositions and methods featuring micronas for treating neoplasia |
| 07/24/2008 | WO2008088849A2 Inflammation treatment, detection and monitoring via trem-1 |
| 07/24/2008 | WO2008088836A2 Compositions and methods for treatment of colorectal cancer |
| 07/24/2008 | WO2008088823A2 Methods for treating psoriasis |
| 07/24/2008 | WO2008088738A2 Novel methods for modulating inflammatory and/or immune responses |
| 07/24/2008 | WO2008088694A2 Regulation of lipid droplet formation by modulation of fit1 and fit2 and uses thereof |
| 07/24/2008 | WO2008088583A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 07/24/2008 | WO2008088582A2 Methods and materials related to trail isoforms |
| 07/24/2008 | WO2008088358A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 07/24/2008 | WO2008088314A2 A composition for the treatment and prevention of peptic ulcer |
| 07/24/2008 | WO2008088301A2 Inhibitors of dnaa activity |
| 07/24/2008 | WO2008087647A2 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle) |
| 07/24/2008 | WO2008087419A2 Animal model for adhd |
| 07/24/2008 | WO2008086881A1 Genetically modified bacteriophages, in particular for combating pathogenic prokaryotes or their pathological effect, and its use and production |
| 07/24/2008 | WO2008070477A9 Polymeric short interfering rna conjugates |
| 07/24/2008 | WO2008063839A9 Targeted delivery of therapeutic agents with lyophilized matrices |
| 07/24/2008 | WO2008063802A9 Suppression of mitochondrial oxidative stress |
| 07/24/2008 | WO2008060356A3 Methods and compositions for gene therapy |
| 07/24/2008 | WO2004090101A3 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 07/24/2008 | WO2004067717A3 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 07/24/2008 | US20080178311 Using vector transformation and direct testis injection as gene delivery tool; human protein expression in non-human mammals |
| 07/24/2008 | US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods |
| 07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
| 07/24/2008 | US20080176798 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176279 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 07/24/2008 | US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms |
| 07/24/2008 | US20080175848 Reducing matrix protein concentration via enzyme inhibitor and plasmin administration; prevention and treatment of fibrosis; wound healing agent |
| 07/24/2008 | US20080175842 Compositions and methods for treatment |
| 07/24/2008 | US20080175832 Materials and Methods for Prevention and Treatment of RNA Viral Diseases |
| 07/24/2008 | US20080175829 Using stem cell culture comprising dibutyryl cAMP and pituitary adenylate cyclase-activating polypeptide (PACAP) as therapeujtic treating spinal cord injuries |
| 07/24/2008 | US20080175827 Treating reproductive disorders via enhancing hydrolase expression; tissue engineering; in vitro fertilization |
| 07/24/2008 | US20080175820 Using vascular endothelial growth factor as wound healing agent; tissue engineering; regenerative medicine; wound healing agent |
| 07/24/2008 | US20080175819 Vector system |
| 07/24/2008 | US20080175818 Using replication-defective plasmid comprising p53 nucleotide sequences as as delivery tool for antitumor agents |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |